'Hidden' breast cancer found in new screening study
A pioneering breast cancer trial involving more than 9,000 patients has found early stages of the disease that might be missed by regular mammograms. Researchers used a range of different scanning methods, including MRI scans and injecting dye into breast tissue, to better understand the disease. More than 1,300 patients in the trial were recruited through Gloucestershire Hospitals NHS Trust.Dr Sarah Vinnicombe, the lead breast radiologist and deputy director of screening at the Thirlestaine Breast Centre in Cheltenham, said she and her colleagues had known for a long time that mammography "even though it's a good screening tool for most women, is not perfect".
The issue, she told BBC Radio Gloucestershire, comes down to the density of breast tissue.People with denser tissue are at a higher risk of developing cancer, but as breast tissue and cancers both appear white on mammograms, early warning signs can be difficult to pick up. The researchers looked at three different ways of picking up early-stage cancers - a whole-breast ultrasound, a quick form of breast MRI and a type of mammogram in which patients are injected with a dye to highlight abnormal areas.With more than 9,000 women involved overall it was the first study ever to take this approach and, Dr Vinnicombe said, it yielded "fascinating" results.
What the researchers found in the group of patients who had the MRI scan or contrast mammogram was a "massive increase in the number of cancers" detected. As for how their findings could impact what women are offered, Dr Vinnicombe said: "There are a lot of conversations going on in the Department of Health and the national screening committee at the moment."It's a work in progress - it's quite clear that we can't just implement contrast mammography or MRI for all those women in the country who have very dense breasts," she added, as this would amount to around 10% of the 2.2 million women screened each year. However, she added, the research had found that not all women with denser breast tissue were at higher risk - meaning the more effective techniques they had identified could be targeted at a smaller group of women.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
EXCLUSIVE How women blighted by cruel back pain may actually have hidden arthritis - as doctors reveal there's a simple drug cure that can end the agony. Special report by ETHAN ENNALS
Clair Evans believes her back pain began during her teens – but she has lived with the debilitating problem for so long that she struggles to remember a time when she wasn't in agony. The 47-year-old from Doncaster says her lower back became extremely stiff, and often the pain would radiate down into her legs. She also found that certain movements triggered excruciating spasms.
Daily Mail
2 hours ago
- Daily Mail
STEPHEN POLLARD: Labour's created an atmosphere where the hard working middle class are now fair game for bigotry
That an eight-year-old can be refused healthcare on the NHS because of the school he attends is deeply troubling. It shows that the service once described by Margaret Thatcher 's Chancellor Nigel Lawson as 'the closest thing the English people have to a religion,' has become a battleground for class war where children seeking treatment are seen as the enemy of the proletariat. That includes my children. I am lucky enough to be able to pay for them to attend private schools. I pay the fees on top of my taxes, of course. Now it seems the NHS regards my kids as non-citizens to be shunned.
Daily Mail
3 hours ago
- Daily Mail
One of NHS's biggest AI projects is halted after fears it used health data of 57 MILLION people without proper permissions
NHS England has paused a ground-breaking AI project designed to predict an individual's risk of health conditions after concerns were raised data from 57 million people was being used without the right permissions. Foresight, which uses Meta 's open-source AI model, Llama 2, was being tested by researchers at University College London and King's College London as part of a national pilot scheme exploring how AI could be used to tailor healthcare plans for patients based on their medical history. But the brakes were applied to the pioneering scheme after experts warned even anonymised records could contain enough information to identify individuals, The Observer reported. A joint IT committee between the British Medical Association (BMA) and the Royal College of General Practitioners (RCGP) also said it they had not been made aware that data collected for research into Covid was now being used to train the AI model. The bodies have also accused the research consortium, led by Health Data Research UK, of failing to consult an advisory body of doctors before feeding the health data of tens of millions of patients into Foresight. Both BMA and RGCP have asked NHS England to refer itself to the Information Commissioner over the matter. Professor Kamila Hawthorne, chair of RGCP, said the issue was one of 'fostering patient trust' that their data was not being used 'beyond what they've given permission for.' She said: 'As data controllers, GPs take the management of their patients' medical data very seriously, and we want to be sure data isn't being used beyond its scope, in this case to train an AI programme. 'We have raised our concerns with NHS England, through the Joint GP IT Committee, and the committee has called for a pause on data processing in this way while further investigation takes place, and for NHS England to refer itself to the Information Commissioner. 'Patients need to be able to trust their personal medical data is not being used beyond what they've given permission for, and that GPs and the NHS will protect their right to data privacy. 'If we can't foster this patient trust, then any advancements made in AI – which has potential to benefit patient care and alleviate GP workload – will be undermined. 'We hope to hear more from NHS England in due course, providing definitive and transparent answers to inform our next steps.' Katie Bramall, BMA England GP committee chair, said: 'For GPs, our focus is always on maintaining our patients' trust in how their confidential data is handled. 'We were not aware that GP data, collected for Covid-19 research, was being used to train an AI model, Foresight. 'As such, we are unclear as to whether the correct processes were followed to ensure that data was shared in line with patients' expectations and established governance processes. 'We have raised our concerns with NHS England through the joint GP IT committee and appreciate their verbal commitment to improve on these processes going forward. 'The committee has asked NHS England to refer itself to the Information Commissioner so the full circumstances can be understood, and to pause ongoing processing of data in this model, as a precaution, while the facts can be established.' 'Patients shouldn't have to worry that what they tell their GP will get fed to AI models without the full range of safeguards in place to dictate how that data is shared.' An NHS spokesperson confirmed that development of the Foresight model had been paused for the time being.
